Physician profile
Armando Cabrera
NPI 1952511495
$611.14
in general payments reported to CMS, 2019-2025
8 companies · $428 in 2025
The $428 reported for 2025 was more than what 81% of Critical Care Medicine (Nurse Practitioner) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.80 · 2023: $51.57 · 2024: $69.95 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $341.19 | 2022-2025 | Tezspire, Fasenra, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $59.97 | 2025 | Glassia |
| Baxter Healthcare | $51.37 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.52 | 2025 | Jascayd |
| Fisher & Paykel Healthcare INC | $46.73 | 2025 | Fisher & Paykel Healthcare |
| Medtronic, INC. | $26.67 | 2023 | Illumisite |
| Glaxosmithkline, LLC. | $20.35 | 2025 | Trelegy Ellipta |
| Phadia US INC. | $17.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Armando Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.